Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005550602
Wed, 11.12.2024
Drägerwerk AG & Co. KGaA
Changes in the chair of the Dräger Supervisory Board
Lübeck – Stefan Lauer, currently Chairman of all Dräger Supervisory Boards, has decided to step down as Chairman at the end of the year for health reasons. The Supervisory Board committees approved this move at their meetings today and passed the following resolutions:
From January 1, 2025, the [ … ]
Fri, 22.11.2024
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission: Extension of the share buyback for the employee stock program
On September 2, 2024, the Executive Board of Drägerwerk Verwaltungs AG had resolved a share buyback for the employee stock program of Dräge [ … ]
Tue, 29.10.2024
Drägerwerk AG & Co. KGaA
Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024
Order intake exceeds high prior-year level
Net sales almost reach the strong prior-year figure
EBIT up around four percent
Annual forecast confirmed
Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first nine months [ … ]
Wed, 16.10.2024
Drägerwerk AG & Co. KGaA
Dräger with good demand in the first nine months of 2024
Order intake exceeds the high prior-year level
Net sales almost reach the strong prior-year figure
EBIT up around four percent
Annual forecast confirmed
Lübeck – Dräger's preliminary order intake rose by 1.4 percent (net of currency effects; nominal: 0.7 percent) to around EUR 2,421 milli [ … ]
Tue, 01.10.2024
Drägerwerk AG & Co. KGaA
Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
On September 2, 2024, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back some [ … ]
Thu, 25.07.2024
Drägerwerk AG & Co. KGaA
Dräger on track to meet annual forecast after a solid first half-year
Order intake slightly above the high prior-year level
Net sales still slightly down so far
EBIT around 17 percent above the prior-year figure
Annual forecast confirmed
Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first half of 2024 thanks to good ov [ … ]
Fri, 12.07.2024
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2024: Earnings above prior year
Lübeck, July 12, 2024 – Dräger's earnings in the first half of the year were up on the prior-year figure despite a slight decline in net sales. Net sales and earnings in the first quarter were still lower [ … ]
Wed, 08.05.2024
Drägerwerk AG & Co. KGaA
Dräger makes sustainability and quality an Executive Board responsibility
Stefanie Hirsch will be appointed to the Executive Board as of July 1, 2024
Dräger is creating a new, additional Executive Board position for sustainability and quality. At its meeting today, the Supervisory Board of Drägerwerk Verwaltungs AG decided to appoint Stefanie Hir [ … ]
Wed, 08.05.2024
Drägerwerk AG & Co. KGaA
Dräger annual shareholders’ meeting approves significant dividend increase
Lübeck – Drägerwerk AG & Co. KGaA held its Annual Shareholders’ Meeting 2024 today. All resolutions on the agenda items were passed with a vast majority. In total, 46.2 percent of the share capital was represented (2023: 45.7 percent).
Dividend
Among the agenda items w [ … ]
Wed, 08.05.2024
Drägerwerk AG & Co. KGaA
Dräger annual shareholders’ meeting approves significant dividend increase
Lübeck – Drägerwerk AG & Co. KGaA held its Annual Shareholders’ Meeting 2024 today. All resolutions on the agenda items were passed with a vast majority. In total, 46.2 percent of the share capital was represented (2023: 45.7 percent).
Dividend
Among the agenda items w [ … ]